Hematology in Israel

Hematology in Israel — Where Experience Meets Determination

Hematology is not just about treating blood — it’s about understanding the human body at its core. Here in Israel, we’ve built our approach over decades. Our doctors, many of whom trained and practiced internationally, work daily with patients from all over the world. People come to us when standard treatments didn’t help — and when time is running out.

At our center, we don’t believe in giving up. We believe in rechecking, reevaluating, and sometimes choosing a different path altogether. Whether it’s an advanced stem cell transplant, targeted therapy, or a clinical trial — we do everything with one goal: giving people a real chance.

Contact Our Hematology Department:
📞 Call us: +972-73-374-6844
📧 Email: [email protected]
💬 WhatsApp: +972-52-337-3108

Our team

Prof. Irit Avivi
Dr. Aviv Fredi

What We Actually Do — Not Just Theory

We treat both malignant and non-malignant blood diseases. That means we see people with leukemia or lymphoma, but also with anemia, platelet problems, and rare clotting disorders.

We’ve structured our hematology services into specialized units, because one size doesn’t fit all. Each patient is different — and so is each disease.

Key Areas of Our Hematology Department

Hemato-Oncology

We deal with blood cancers: chronic and acute leukemias, lymphomas, myeloma. These are some of the toughest diagnoses — but also where modern medicine has made huge progress.

General Hematology

This unit focuses on things like chronic anemia, blood clotting disorders, and bone marrow failure that isn’t related to cancer. You don’t always need chemo to need a hematologist.

Bone Marrow Transplantation

Our transplant team handles the entire process — from evaluation and donor matching, through conditioning therapy, to post-transplant follow-up. Both autologous and allogeneic transplants are performed here.

Apheresis and Cell Collection

We have a unit for collecting and separating blood components, both for donors and for treatments like plasma exchange.

What Conditions We Treat – The Full Picture

We see a wide range of patients — some newly diagnosed, others already deep into treatment. Some come with biopsy reports in hand, others with only symptoms and no answers.

These are the conditions we treat most often:

Acute myeloid leukemia (AML)
Acute lymphoblastic leukemia (ALL)
Chronic myeloid leukemia (CML)
Chronic lymphocytic leukemia (CLL)
Hodgkin’s and non-Hodgkin’s lymphomas
Multiple myeloma
Myelodysplastic syndromes (MDS)
Aplastic anemia
Myelofibrosis
Rare bone marrow disorders

And also non-cancerous conditions like:

Severe anemia (including iron-resistant or genetic forms)
Platelet disorders (ITP, thrombocytopenia)
Coagulation problems (both bleeding and clotting disorders)
Paroxysmal nocturnal hemoglobinuria (PNH)
Thalassemia and sickle cell disease

In some cases, patients don’t have a clear diagnosis when they arrive. That’s okay. Our job is to help figure it out — from the first blood test to the most advanced biopsy.

How We Diagnose – Accuracy Without Delay

We try to avoid wasting time. That’s why most of the tests are done here in-house, without referring you from place to place.

Depending on the case, we might perform:

Complete blood count, chemistry, immune panels
Coagulation tests
Bone marrow biopsy with full myelogram
Lymph node biopsies (fine needle or surgical)
Flow cytometry and immunophenotyping
Cytogenetics and molecular diagnostics
Ultrasound or CT-guided biopsy
High-resolution imaging: MRI, CT, PET-CT
Gallium scans (in select lymphoma cases)
Lumbar puncture (if CNS involvement is suspected)

We don’t order every test “just in case.” We focus on what’s really needed — but when we do it, we do it fast and thoroughly.

How We Treat — The Tools That Matter

Bone Marrow Transplantation (BMT)

One of the most powerful tools we have. Depending on the diagnosis, we might recommend an autologous transplant (your own cells, reinfused after chemo) or an allogeneic one (from a donor).
We use both related and unrelated donor registries — sometimes international — and handle everything from conditioning to isolation care on-site.

CAR-T Cell Therapy

This isn’t for everyone, but when it’s indicated, it can be life-changing. We extract your T-cells, modify them to attack your cancer, and reintroduce them. It’s mostly used for resistant leukemias and lymphomas.

Targeted Therapy and Monoclonal Antibodies

Some drugs aren’t chemotherapy — they’re smart. Medications like rituximab and others target cancer cells without damaging healthy tissue. We use them alone or combined with other treatments.

Chemotherapy

Still a backbone of hematologic treatment — but we use it carefully. Doses are tailored. Combinations are adjusted. And supportive therapy is always part of the plan.

Blood Product Support

When hemoglobin drops or platelets crash, we step in. Our blood bank follows strict donor testing. Transfusions are safe, fast, and closely monitored.

Beyond the Medicine — Real Support for Patients and Families

No one should go through this alone. At TAMC, we assign a coordinator to every international patient. They help with documents, language, appointments — and honestly, just being there when things get overwhelming.

We also have a team for psychological support, rehabilitation, and long-term follow-up. Because surviving cancer is one thing — recovering your life afterward is another.

Frequently Asked Questions – Answered by Prof. Irit Avivi and Dr. Aviv Fredi

Should I really consider coming to Israel for hematology care?

Prof. Irit Avivi:
I think in many cases — it’s not just worth considering, it’s the right decision. We’ve had patients come to us after trying almost everything back home, and… things just weren’t moving forward.
Here, we don’t just look at your papers — we re-evaluate everything. Sometimes it’s about offering a treatment like CAR-T or a transplant, and other times it’s just about seeing your case from a different angle.
We can move fast too — which matters when you’re dealing with a blood cancer. In some cases, we’ve started workups within a day or two after arrival.

What’s different about private hematology care?

Dr. Aviv Fredi:
You know, it’s not just the speed — though that’s a big part of it. What I notice is that in private care, we’re able to focus on the patient fully. No rushing. No bureaucracy.
If I need a scan or a test, I don’t wait for committee approvals or scheduling issues — we just do it.
And it’s not just about tests. We stay with you — from diagnosis through treatment and after. We know your name. You’re not just another file.

They told me there’s no more treatment for my leukemia. Do I still have a chance?

Prof. Avivi:
Look, I’ve had so many families tell me that. And I never answer that kind of question without sitting down, reading every page of their history, and looking again at the pathology and scans.
Sometimes it really is time to stop. But in many cases, it’s not. We’ve treated people who were told there’s no hope, and now they’re in remission.
That doesn’t mean we promise miracles. But we don’t give up before we’ve tried everything reasonable — and sometimes, things change when you look at them from another point of view.

How quickly can treatment start once I contact you?

Dr. Aviv Fredi:
Honestly, much faster than most people expect. Once we have your medical records — even just scanned PDFs or a summary — we usually get back to you within a day.
Initial consultation? We can often set that up in 48 hours or less. And if we’re talking about a transplant or CAR-T? Prep begins almost immediately.
We know how fast some of these diseases move. So we move fast too. That’s one of the key benefits of working privately — no waiting lists.

What are your success rates with bone marrow transplants?

Prof. Irit Avivi:
It’s a question we’re asked all the time — and rightly so.
The short answer is: our results are very strong, and comparable with top centers in Europe or North America. But here’s what I always tell families — success depends on many factors. Type of disease. Stage. Donor match. Age. Overall health.
What we do differently is tailor the entire process — from conditioning to follow-up — to the individual. It’s not one-size-fits-all. That’s a big part of why our patients do well.

Do you provide CAR-T therapy for international patients too?

Dr. Aviv Fredi:
Yes, absolutely. In fact, a growing number of people come to us from abroad specifically for CAR-T.
We manage everything: evaluation, collection of T-cells, coordination with the lab that modifies them, and the infusion itself. The whole process happens under one roof, and we’re with you the entire way.
It’s not for everyone, and not every case qualifies — but when it’s the right match, the results can be remarkable.

Can I contact you just to get a second opinion?

Prof. Irit Avivi:
Of course. In fact, that’s how many of our conversations begin.
Some families aren’t sure about the treatment plan they were given. Others just want a fresh pair of eyes before making a decision.
We review all your tests and pathology carefully, and we’ll tell you exactly what we think — even if that means saying, “your doctors are doing everything right.”
And if we see something different? We’ll explain it clearly and without pressure. You deserve to know all your options.

Told there’s nothing left to try? Let us take another look.
Our team specializes in difficult and relapsed cases — it’s not too late to ask again.